PHSRX Mutual Fund

PHSRX Mutual Fund

NAV$59.87
See how much of PHSRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of May 31, 2026

Net Assets
-
Expense Ratio
1.29%
Dividend Yield (Current)
0.18%
Holdings
119
Inception Date
Jan 21, 2003
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.08%
1 Year+24.66%
3 Year+8.51%
5 Year+6.07%
10 Year+8.76%

Asset Allocation

Stocks: 97.97%
Bonds: 0.17%
Cash: 1.86%
See how much of PHSRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.13.16%
JNJJohnson & Johnson - Common8.47%
UNHUnitedhealth Group Incorporated6.94%
ABBVAbbvie Inc.6.05%
NOVN:SMNovartis Ag Ordinary Shares5.14%
Top 10 Concentration: 61.11%Report Date: May 31, 2026
Download all 119 holdings for PHSRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.18%
Frequency
Annually
Latest Distribution
$5.50
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PHSRX Mutual Fund Overview

PHSRX Mutual Fund (Putnam Global Health Care Fund Class R) is managed by Putnam Investments. PHSRX expense ratio is 1.29%, holding 119 positions across sectors including Health Care. Inception date: 2003-01-21.

PHSRX performance shows a YTD return of 3.08%. The 1-year return is 24.66% and the 5-year return is 6.07%. PHSRX dividend yield stands at 0.18%, paid annually.

PHSRX top holdings include Eli Lilly & Co. (13.2%), Johnson & Johnson - Common (8.5%), Unitedhealth Group Incorporated (6.9%), Abbvie Inc. (6.0%), Novartis Ag Ordinary Shares (5.1%). Go to all PHSRX holdings, PHSRX sectors, or PHSRX dividends.

PHSRX can be compared against other funds. Use PHSRX overlap to find shared positions, or PHSRX vs another fund for a side-by-side view. PHSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.